These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

696 related items for PubMed ID: 15563759

  • 1. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
    Hu L, Tang X, Cui F.
    J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
    [Abstract] [Full Text] [Related]

  • 2. Improvement of digoxin oral absorption in rabbits by incorporation into solid lipid nanoparticles.
    Hu L, Jia H, Luo Z, Liu C, Xing Q.
    Pharmazie; 2010 Feb; 65(2):110-3. PubMed ID: 20225654
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles.
    Varshosaz J, Minayian M, Moazen E.
    J Liposome Res; 2010 Jun; 20(2):115-23. PubMed ID: 19694503
    [Abstract] [Full Text] [Related]

  • 4. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo].
    Hu LD, Tang X, Cui FD.
    Yao Xue Xue Bao; 2005 Jan; 40(1):71-5. PubMed ID: 15881775
    [Abstract] [Full Text] [Related]

  • 5. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
    Paliwal R, Rai S, Vaidya B, Khatri K, Goyal AK, Mishra N, Mehta A, Vyas SP.
    Nanomedicine; 2009 Jun; 5(2):184-91. PubMed ID: 19095502
    [Abstract] [Full Text] [Related]

  • 6. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability.
    Luo Y, Chen D, Ren L, Zhao X, Qin J.
    J Control Release; 2006 Aug 10; 114(1):53-9. PubMed ID: 16828192
    [Abstract] [Full Text] [Related]

  • 7. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
    Ye J, Wang Q, Zhou X, Zhang N.
    Int J Pharm; 2008 Mar 20; 352(1-2):273-9. PubMed ID: 18054182
    [Abstract] [Full Text] [Related]

  • 8. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability.
    Varshosaz J, Tabbakhian M, Mohammadi MY.
    J Liposome Res; 2010 Dec 20; 20(4):286-96. PubMed ID: 19958118
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.
    Manjunath K, Venkateswarlu V.
    J Control Release; 2005 Oct 03; 107(2):215-28. PubMed ID: 16014318
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang Z, Lv H, Zhou J.
    Pharmazie; 2009 Sep 03; 64(9):574-8. PubMed ID: 19827297
    [Abstract] [Full Text] [Related]

  • 12. Enhanced Oral Absorption of All-trans Retinoic Acid upon Encapsulation in Solid Lipid Nanoparticles.
    Kumar M, Sharma G, Singla D, Singh S, Kakkar V, Gulati JS, Kaur IP.
    Pharm Nanotechnol; 2020 Sep 03; 8(6):495-510. PubMed ID: 33115399
    [Abstract] [Full Text] [Related]

  • 13. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
    Silva AC, Kumar A, Wild W, Ferreira D, Santos D, Forbes B.
    Int J Pharm; 2012 Oct 15; 436(1-2):798-805. PubMed ID: 22867992
    [Abstract] [Full Text] [Related]

  • 14. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system.
    Chalikwar SS, Belgamwar VS, Talele VR, Surana SJ, Patil MU.
    Colloids Surf B Biointerfaces; 2012 Sep 01; 97():109-16. PubMed ID: 22609590
    [Abstract] [Full Text] [Related]

  • 15. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N, Janga KY.
    Drug Dev Ind Pharm; 2017 Jul 01; 43(7):1205-1214. PubMed ID: 28274147
    [Abstract] [Full Text] [Related]

  • 16. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A, Hoffman A.
    J Control Release; 2008 Jul 02; 129(1):1-10. PubMed ID: 18499294
    [Abstract] [Full Text] [Related]

  • 17. [Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles].
    He J, Hou SX, Feng JF, Cai BQ.
    Zhongguo Zhong Yao Za Zhi; 2005 Nov 02; 30(21):1651-3. PubMed ID: 16400939
    [Abstract] [Full Text] [Related]

  • 18. Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles.
    Yang L, Geng Y, Li H, Zhang Y, You J, Chang Y.
    Pharmazie; 2009 Feb 02; 64(2):86-9. PubMed ID: 19320279
    [Abstract] [Full Text] [Related]

  • 19. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang N, Ping Q, Huang G, Xu W, Cheng Y, Han X.
    Int J Pharm; 2006 Dec 11; 327(1-2):153-9. PubMed ID: 16935443
    [Abstract] [Full Text] [Related]

  • 20. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.
    Han SF, Yao TT, Zhang XX, Gan L, Zhu C, Yu HZ, Gan Y.
    Int J Pharm; 2009 Sep 08; 379(1):18-24. PubMed ID: 19508887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.